Vivani Medical Develops GLP-1 Implant for Weight Loss

Vivani Medical is innovating a tiny implant containing semaglutide, the active ingredient in popular obesity and diabetes medications, as a new method to help patients sustain weight loss.

11 Jul, 12:00 — 11 Jul, 12:00

Post Share

Sources

Showing 1 of 1 sources

cnbcMostly Factual50d ago

A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.

Read full article →

Vivani Medical Develops GLP-1 Implant for Weight Loss

Sources

A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

Related Stories

NATO Warns of Escalating Russian Gray Zone Attacks Across Europe

Trump Administration Announces Major Oil Deal to Replenish U.S. Strategic Reserve

Investors Eye Jobs Data and Major Earnings Reports for Market Direction

North Korea Replaces Defense Minister in Military Shake-Up